ArticleNeoplasia (New York, N.Y.)2017

Corrigendum to "Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer" [Neoplasia 19 (2017) 145-153].

Ki Cheong Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.